I guess I was confused by this statement on the in
Post# of 148278
(Total Views: 599)
Posted On: 08/22/2021 4:41:55 PM
I guess I was confused by this statement on the interim analysis:
Preliminary Interim Task 1 Report:
Pre-Analysis of mTNBC from Trial 756 (Compassionate Use) and Trial 706 (mTNBC)
▪ Goal of Interim Analysis is to compare PFS and OS in relation to
Standard of Care (SOC) or Sacituzumab Govitecan (SG) Trial
▪ Goal one: Have a mPFS >2.3 (SOC) or >5.6 (SG)
▪ Goal two: Have a mOS >6.7 (SOC) or >12.1 (SG)
Notice that mOS is nowhere mentioned in the outcomes.
Preliminary Interim Task 1 Report:
Pre-Analysis of mTNBC from Trial 756 (Compassionate Use) and Trial 706 (mTNBC)
▪ Goal of Interim Analysis is to compare PFS and OS in relation to
Standard of Care (SOC) or Sacituzumab Govitecan (SG) Trial
▪ Goal one: Have a mPFS >2.3 (SOC) or >5.6 (SG)
▪ Goal two: Have a mOS >6.7 (SOC) or >12.1 (SG)
Notice that mOS is nowhere mentioned in the outcomes.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼